FDA — authorised 20 November 2001
- Application: NDA021319
- Marketing authorisation holder: WAYLIS THERAP
- Status: supplemented
FDA authorised Avodart on 20 November 2001
Yes. FDA authorised it on 20 November 2001; FDA has authorised it.
WAYLIS THERAP holds the US marketing authorisation.